David Shaw’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-10,000
Closed -$266K – 5628
2021
Q4
$266K Hold
10,000
– – ﹤0.01% 4735
2021
Q3
$411K Sell
10,000
-70,000
-88% -$3.84M ﹤0.01% 4195
2021
Q2
$4.53M Buy
+80,000
New +$2.95M ﹤0.01% 2143
2019
Q1
– Sell
-40,000
Closed -$910K – 3671
2018
Q4
$910K Buy
+40,000
New +$1.09M ﹤0.01% 2726

Other funds holding EDIT

David Shaw's EDIT Position: Q3 2026 in Review

David Shaw increased its Editas Medicine (EDIT) stake by 68% in Q3 2026, buying an estimated $3.78M and bringing the position to 3,190,146 shares worth $8.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1991.

David Shaw first reported a position in EDIT in Q4 2016 and has held it in 40 quarters since. The position peaked at $98.8M in Q4 2020. 221 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • David Shaw held 3,190,146 shares of Editas Medicine worth $8.2M as of Q3 2026.
  • David Shaw bought 1,289,144 Editas Medicine shares in Q3 2026, an estimated $3.78M.
  • Editas Medicine made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #1991 holding.
  • David Shaw first reported a position in Editas Medicine in Q4 2016 and has held it in 40 quarters since.
  • David Shaw's Editas Medicine position peaked at $98.8M in Q4 2020.
  • 221 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.